Fears of a link between testosterone replacement therapy and cardiovascular risk are misplaced, shows a review published in this month's iMayo Clinic Proceedings/i. The therapy has come under widespread scrutiny in recent months, including by a federal Food and Drug Administration (FDA) panel convened last fall. "There's no good evidence that we could find that testosterone therapy increases cardiovascular risk," says lead author Abraham Morgentaler, ...
Read More
You have just read an article categorized health
titled Linkage Between Testosterone Therapy And Cardiovascular Risk are Misplaced.
Written by:
editor -
Tuesday, January 27, 2015
There are currently no comments for "Linkage Between Testosterone Therapy And Cardiovascular Risk are Misplaced"
Post a Comment